Screener
OrthoPediatrics KIDS Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by OrthoPediatrics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: OrthoPediatrics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 1:56 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001425450-26-000070
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net loss | $(17,850) | $(17,772) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 11,427 | 10,218 |
| Stock-based compensation | 8,173 | 9,111 |
| Accretion of acquisition installment payable | 220 | 98 |
| Deferred income taxes | (82) | 245 |
| Non-cash other | 161 | (100) |
| Changes in certain operating assets and liabilities: |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is OrthoPediatrics's stock-based comp?
- OrthoPediatrics (KIDS) reported stock-based comp of $4.19M in Q2 2026.
- How has OrthoPediatrics's stock-based comp changed year-over-year?
- OrthoPediatrics's stock-based comp decreased by 20.2% year-over-year, from $5.25M to $4.19M.
- What is the long-term trend for OrthoPediatrics's stock-based comp?
- Over 4 years (2021 to 2025), OrthoPediatrics's stock-based comp has grown at a 32.1% compound annual growth rate (CAGR), from $5.84M to $17.78M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about OrthoPediatrics's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude